This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Henry H. Balfour, Jr, MD

JAMA. 1986;255(3):387-388.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Acyclovir sodium administered intravenously to treat acute herpes zoster in an immunocompromised patient was associated with side effects as described by Sylvester et al in this issue of THE JOURNAL.¹ The CASE REPORT raises several important questions: Should acyclovir be used for treatment of herpes zoster, and, if so, what dosage is appropriate and what adverse effects can be expected?

Acyclovir is a specific inhibitor of the DNA polymerase of all five members of the human herpesvirus family and thus the drug is potentially useful for treatment of many herpes-virus-associated diseases.

The median sensitivity of herpes simplex virus (HSV) type 2 strains to acyclovir as measured by plaque reduction is 0.4µM.² Plasma concentrations fivefold higher than this can be attained by ingesting one 200-mg acyclovir capsule. Therefore, it is not surprising that acyclovir is the drug of choice for treatment of primary³ and recurrent⁴ genital herpes, herpes . . . [Full Text PDF of this Article]

Author Affiliations
University of Minnesota Health Sciences Center Minneapolis

Footnotes
Address editorial communications to the Editor, 535 N Dearborn St, Chicago, IL 60610.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?